IL33 and systemic sclerosis: Because IL-33 produced by dermal fibroblasts contributes to Th2-like Treg transdifferentiation in the lesional skin of patients with SSc [2], we next evaluated IL-33 expression in the skin of BLM-treated Fli1+/− mice.